PCRX

Rank #87

Rank #87 by gross profitability (GP/assets 0.48) · ROE 1.1% · Piotroski F-Score N/A.

As-of 2026-07-22 · CIK 0001396814 · all metrics point-in-time as of the filing date.

Profitability

Gross profitability (GP / assets)

0.48

Primary signal (Novy-Marx).

Return on equity

1.1%

Gross margin

79.4%

Revenue growth (YoY)

69.1%

Gross margin improving

Margin trend vs prior year.

PASS

Anti-fragile safety

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

0.85

Current ratio

4.73×

Quick ratio

3.01×

Net cash

-$165.48M

Cash & equivalents minus total debt.

Cash-flow health

Free cash flow

$136.66M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF / net income

18.43

Cash-backing of earnings.

FCF/NI divergence

Unfavorable divergence (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

7.9%

Stock-based comp intensity.

Piotroski F-Score

F-Score

N/A

Only 8/9 components determinable.

View full financial statements →